Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rodent models of cholestatic liver disease: A practical guide for translational research
Eva Gijbels, Alanah Pieters, Kevin De Muynck, et al.
Liver International (2021) Vol. 41, Iss. 4, pp. 656-682
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans
Francisco J. Caballero‐Camino, Pedro M. Rodrigues, Fredrik Wångsell, et al.
Hepatology (2023) Vol. 78, Iss. 3, pp. 709-726
Open Access | Times Cited: 21
Ribes diacanthum Pall modulates bile acid homeostasis and oxidative stress in cholestatic mice by activating the SIRT1/FXR and Keap1/Nrf2 signaling pathways
Alamusi Bayoude, Jiaxin Zhang, Ya Shen, et al.
Journal of Ethnopharmacology (2025), pp. 119400-119400
Closed Access
Engineered Exosomes Carrying Super-Repressor IκB Reduced Biliary Atresia-Induced Liver Fibrosis in Minipig and Mouse Models
Jisoo Kang, Cheolhyoung Park, Hanoul Yun, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 264-264
Open Access
A critical review of microbiome-derived metabolic functions and translational research in liver diseases
Raja Ganesan, Durairaj Thirumurugan, Saranya Vinayagam, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Chenodeoxycholic acid modulates cholestatic niche through FXR/Myc/P-selectin axis in liver endothelial cells
Peng Zhang, Minghao Yin, Jinyuan Liang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Animal models of biliary/cholestatic disease
Savneet Kaur, Dinesh Mani Tripathi
Elsevier eBooks (2025), pp. 185-214
Closed Access
Short-chain fatty acids alleviate cholestatic liver injury by improving gut microbiota and bile acid metabolism
Lu Han, Mingmin Zhang, Yanan Hu, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114564-114564
Closed Access
The efficacy and toxicity equilibrium of emodin for liver injury: A bidirectional meta-analysis and machine learning
Sihan Hu, Xiaochuan Guo, Le-Mai Tu, et al.
Phytomedicine (2025), pp. 156650-156650
Closed Access
A nonbile acid farnesoid X receptor agonist tropifexor potently inhibits cholestatic liver injury and fibrosis by modulating the gut–liver axis
Yongtao Xiao, Ying Wang, Liu Yang, et al.
Liver International (2021) Vol. 41, Iss. 9, pp. 2117-2131
Closed Access | Times Cited: 32
The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
Kevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2959-2959
Open Access | Times Cited: 30
Research progress on rodent models and its mechanisms of liver injury
Jingxin Mao, Lihong Tan, Tian Cheng, et al.
Life Sciences (2023) Vol. 337, pp. 122343-122343
Open Access | Times Cited: 12
The gut microbiota-bile acid axis in cholestatic liver disease
Dayan Sun, Chuanping Xie, Yong Zhao, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 4
Livogrit Mitigates ANIT-Induced Cholestasis-Like Symptoms in an In Vivo model by Curbing Hepatic Inflammation and Regulating BAX, TGF-β, MMP-9 and α-SMA Gene Expression
Acharya Balkrishna, Ritu Paliwal, Surjeet Singh, et al.
Heliyon (2025) Vol. 11, Iss. 3, pp. e41855-e41855
Open Access
Discovery of the First Subnanomolar PPARα/δ Dual Agonist for the Treatment of Cholestatic Liver Diseases
Zhiqi Feng, Jiehao Xiang, Gang Sun, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 11, pp. 7331-7354
Closed Access | Times Cited: 10
Geniposide alleviated bile acid-associated NLRP3 inflammasome activation by regulating SIRT1/FXR signaling in bile duct ligation-induced liver fibrosis
Tingting Qin, Muhammad Hasnat, Ziwei Wang, et al.
Phytomedicine (2023) Vol. 118, pp. 154971-154971
Closed Access | Times Cited: 10
Optimization of an adverse outcome pathway network on chemical-induced cholestasis using an artificial intelligence-assisted data collection and confidence level quantification approach
J. van Ertvelde, A. Verhoeven, Amy Maerten, et al.
Journal of Biomedical Informatics (2023) Vol. 145, pp. 104465-104465
Open Access | Times Cited: 10
Kupffer Cells Contested as Early Drivers in the Pathogenesis of Primary Sclerosing Cholangitis
Kevin De Muynck, Bart Vanderborght, Federico F. De Ponti, et al.
American Journal Of Pathology (2023) Vol. 193, Iss. 4, pp. 366-379
Open Access | Times Cited: 9
Ductular Reactions in Liver Injury, Regeneration, and Disease Progression—An Overview
Nirmala Mavila, Mallikarjuna Siraganahalli Eshwaraiah, J. Kennedy
Cells (2024) Vol. 13, Iss. 7, pp. 579-579
Open Access | Times Cited: 3
Isoastragaloside I attenuates cholestatic liver diseases by ameliorating liver injury, regulating bile acid metabolism and restoring intestinal barrier
Linzhang Zhang, Xiaoyu Jiang, Jiewen Shi, et al.
Journal of Ethnopharmacology (2024) Vol. 335, pp. 118649-118649
Closed Access | Times Cited: 3
Targeted bile acid profiles reveal the liver injury amelioration of Da-Chai-Hu decoction against ANIT- and BDL-induced cholestasis
Yuehua Zhou, YunZhong Zhou, Yifei Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Protective Effects of Bee Venom-Derived Phospholipase A2 against Cholestatic Liver Disease in Mice
Jung‐Yeon Kim, Hyo-Jeong Jang, Jaechan Leem, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 992-992
Open Access | Times Cited: 19
Inhibition of CBP/β‐catenin signaling ameliorated fibrosis in cholestatic liver disease
Masamichi Kimura, Koji Nishikawa, Yosuke Osawa, et al.
Hepatology Communications (2022) Vol. 6, Iss. 10, pp. 2732-2747
Open Access | Times Cited: 13
Alleviation of cholestatic liver injury and intestinal permeability by lubiprostone treatment in bile duct ligated rats: role of intestinal FXR and tight junction proteins claudin-1, claudin-2, and occludin
Fereydoon Safari, Mohammadreza Sharifi, Ardeshir Talebi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 9, pp. 2009-2022
Closed Access | Times Cited: 6
Gentiopicroside Ameliorated Ductular Reaction and Inflammatory Response in DDC-induced Murine Cholangiopathies Model
Juan Hao, Yi Xu, Kan V. Lu, et al.
Current Molecular Pharmacology (2023) Vol. 17
Open Access | Times Cited: 5
Gestational cholestasis induced intrauterine growth restriction through triggering IRE1α‐mediated apoptosis of placental trophoblast cells
Xingxing Gao, Shuai Lin, Pei‐Ying Jiang, et al.
The FASEB Journal (2022) Vol. 36, Iss. 7
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top